Polymer Capital Management »

Arrivent Biopharma shares owned by Polymer Capital Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Polymer Capital Management from 13F filings

Historical chart of Polymer Capital Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Polymer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Polymer Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 122k 23.07

More positions owned by Polymer Capital Management

Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Eli Lilly & Co. (LLY)
Sandisk Corp (SNDK)
Spdr Gold Tr Gold Shs Call Option (GLD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alnylam Pharmaceuticals (ALNY)
Vipshop Hldgs Sponsored Ads A (VIPS)
Gildan Activewear Inc Com Cad (GIL)
Select Sector Spdr Tr State Street Ene (XLE)
Alphabet Cap Stk Cl C (GOOG)
Palo Alto Networks (PANW)
Amazon Call Option (AMZN)

View all positions for Polymer Capital Management

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
Vanguard Capital Management
General Catalyst Group Management
State Street Corporation
Vivo Capital
Goldman Sachs Group

View all funds holding Arrivent Biopharma